Foster & Motley Inc Amgen Inc Transaction History

Foster & Motley Inc

  • $1.58 Billion
  • Q3 2024

A detailed history of Foster & Motley Inc transactions in Amgen Inc stock. As of the latest transaction made, Foster & Motley Inc holds 35,235 shares of AMGN stock, worth $10.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
35,235
Previous 36,537 3.56%
Holding current value
$10.4 Million
Previous $11.4 Million 0.55%
% of portfolio
0.72%
Previous 0.78%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$309.38 - $337.38 $402,812 - $439,268
-1,302 Reduced 3.56%
35,235 $11.4 Million
Q2 2024

Aug 02, 2024
SELL
$262.75 - $319.31 $183,399 - $222,878
-698 Reduced 1.87%
36,537 $11.4 Million
Q1 2024

Apr 18, 2024
SELL
$268.87 - $324.56 $77,972 - $94,122
-290 Reduced 0.77%
37,235 $10.6 Million
Q4 2023

Feb 01, 2024
BUY
$255.7 - $288.46 $8,182 - $9,230
32 Added 0.09%
37,525 $10.8 Million
Q3 2023

Oct 24, 2023
BUY
$218.65 - $271.46 $15,086 - $18,730
69 Added 0.18%
37,493 $10.1 Million
Q2 2023

Aug 08, 2023
BUY
$214.27 - $253.37 $143,346 - $169,504
669 Added 1.82%
37,424 $8.31 Million
Q1 2023

May 09, 2023
BUY
$225.79 - $275.2 $629,502 - $767,257
2,788 Added 8.21%
36,755 $8.89 Million
Q4 2022

Feb 09, 2023
SELL
$229.03 - $291.01 $90,695 - $115,239
-396 Reduced 1.15%
33,967 $8.92 Million
Q3 2022

Nov 04, 2022
SELL
$224.46 - $253.15 $68,460 - $77,210
-305 Reduced 0.88%
34,363 $7.75 Million
Q2 2022

Aug 09, 2022
SELL
$230.71 - $256.74 $201,640 - $224,390
-874 Reduced 2.46%
34,668 $8.44 Million
Q1 2022

Apr 28, 2022
SELL
$219.27 - $242.57 $235,057 - $260,035
-1,072 Reduced 2.93%
35,542 $8.6 Million
Q4 2021

Jan 25, 2022
SELL
$198.88 - $227.6 $301,104 - $344,586
-1,514 Reduced 3.97%
36,614 $8.24 Million
Q3 2021

Oct 29, 2021
SELL
$212.27 - $248.7 $250,266 - $293,217
-1,179 Reduced 3.0%
38,128 $8.11 Million
Q2 2021

Jul 20, 2021
SELL
$233.58 - $259.14 $117,724 - $130,606
-504 Reduced 1.27%
39,307 $9.58 Million
Q1 2021

Apr 26, 2021
SELL
$221.91 - $258.6 $257,859 - $300,493
-1,162 Reduced 2.84%
39,811 $9.91 Million
Q4 2020

Feb 01, 2021
SELL
$216.38 - $257.67 $180,460 - $214,896
-834 Reduced 1.99%
40,973 $9.42 Million
Q3 2020

Oct 19, 2020
SELL
$234.65 - $260.95 $708,643 - $788,069
-3,020 Reduced 6.74%
41,807 $10.6 Million
Q2 2020

Jul 20, 2020
SELL
$197.81 - $242.74 $466,238 - $572,138
-2,357 Reduced 5.0%
44,827 $10.6 Million
Q1 2020

Apr 21, 2020
BUY
$182.24 - $241.7 $63,784 - $84,595
350 Added 0.75%
47,184 $9.57 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $469,619 - $603,622
-2,482 Reduced 5.03%
46,834 $11.3 Million
Q3 2019

Oct 24, 2019
BUY
$174.11 - $208.62 $54,148 - $64,880
311 Added 0.63%
49,316 $9.54 Million
Q2 2019

Jul 17, 2019
BUY
$166.7 - $195.41 $38,341 - $44,944
230 Added 0.47%
49,005 $9.03 Million
Q1 2019

May 08, 2019
BUY
$180.87 - $203.88 $614,596 - $692,784
3,398 Added 7.49%
48,775 $9.27 Million
Q4 2018

Jan 30, 2019
BUY
$178.4 - $208.25 $16,056 - $18,742
90 Added 0.2%
45,377 $8.83 Million
Q3 2018

Oct 31, 2018
SELL
$185.29 - $208.89 $314,622 - $354,695
-1,698 Reduced 3.61%
45,287 $9.39 Million
Q2 2018

Jul 24, 2018
SELL
$166.05 - $186.51 $15,442 - $17,345
-93 Reduced 0.2%
46,985 $8.67 Million
Q1 2018

May 14, 2018
SELL
$169.43 - $198.0 $2,710 - $3,168
-16 Reduced 0.03%
47,078 $8.03 Million
Q4 2017

Jan 22, 2018
BUY
$168.79 - $188.59 $96,885 - $108,250
574 Added 1.23%
47,094 $8.19 Million
Q3 2017

Oct 19, 2017
BUY
$167.29 - $191.0 $7.78 Million - $8.89 Million
46,520
46,520 $8.67 Million

Others Institutions Holding AMGN

# of Institutions
3,113
Shares Held
410M
Call Options Held
7M
Put Options Held
6.15M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email